Clinical Trial Update: Effect of Inulin on Gut Microbiota and Gut Barrier in Chronic Kidney Disease [NA]

View source ↗

Summary

A clinical trial is evaluating the effect of inulin on gut microbiota and gut barrier in chronic kidney disease, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Inulin (inulin)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Chronic Kidney Disease 5D | NA | Status: RECRUITING